<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font6" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font7" size="6" family="GillSans" color="#000000"/>
	<fontspec id="font8" size="8" family="GillSans,Italic" color="#000000"/>
<text top="41" left="55" width="88" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">CytoJournal 2007, 4 :7<i>CytoJournal</i></text>
<text top="41" left="392" width="162" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.cytojournal.com/content/4/1/7</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="114" segment_no="12" tag_type="text">Page 6 of 10<b>4</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="115" segment_no="13" tag_type="text">(page number not for citation purposes)</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="48" segment_no="6" tag_type="text">ASC-H patterns may represent hyperchromatic crowded</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="49" segment_no="6" tag_type="text">groups which should be scrutinized carefully for proper</text>
<text top="345" left="55" width="190" height="9" font="font4" id="p1_t7" reading_order_no="50" segment_no="6" tag_type="text">interpretation as reported previously [21,22].<i>(page number not for citation purposes)</i></text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="51" segment_no="8" tag_type="text">The management of LSIL-H cases has not been addressed</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="52" segment_no="8" tag_type="text">currently by the ASCCP guidelines [6,22-25]. Based on the</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="53" segment_no="8" tag_type="text">biopsy pattern in this study and review of the literature,<a href="">eviously [21</a>,<a href="">22].</a></text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="54" segment_no="8" tag_type="text">the initial management may be similar to that of LSIL with</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="55" segment_no="8" tag_type="text">referral to colposcopy [6,7], but the subsequent approach<a href="">6,22-25</a>]. Based on the</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="56" segment_no="8" tag_type="text">may be comparable to HSIL (and ASC-H) (Figure 5). Or,</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="57" segment_no="8" tag_type="text">the management may be entirely similar to ASC-H. Some</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="58" segment_no="8" tag_type="text">of the issues to be considered while planning manage-<a href=""> [6,7], but</a> the subsequent approach</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="59" segment_no="8" tag_type="text">ment guidelines include: A. How to manage patients with<a href="">e 5). Or,</a></text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="60" segment_no="8" tag_type="text">negative or unsatisfactory colposcopy results? B. Would a</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="61" segment_no="8" tag_type="text">conservative approach similar to LSIL or ASC-H cases be</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="62" segment_no="8" tag_type="text">optimum? C. Should endocervical sampling be obtained</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="63" segment_no="8" tag_type="text">if the colposcopic examination is satisfactory? D. Would a</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="64" segment_no="8" tag_type="text">cone biopsy similar to HSIL cases ever be indicated in</text>
<text top="533" left="55" width="128" height="9" font="font4" id="p1_t22" reading_order_no="65" segment_no="8" tag_type="text">evaluation of LSIL-H category?</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="66" segment_no="10" tag_type="text">As the risk of high grade dysplasia associated with LSIL-H</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="67" segment_no="10" tag_type="text">is comparable with ASC-H, (Table 1, Figure 4) and the</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="68" segment_no="10" tag_type="text">association with lower incidence of negative results is sim-</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="69" segment_no="10" tag_type="text">ilar to LSIL, it is reasonable to apply some combination of</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="70" segment_no="10" tag_type="text">ASC-H and LSIL management guidelines. Possible appli-<a href="">1, Figure 4)</a> and the</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="71" segment_no="10" tag_type="text">cation of the HSIL approach at later stages of the algo-</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="72" segment_no="10" tag_type="text">rithm may be needed (Figure 5). For ASC-H and LSIL,</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="73" segment_no="10" tag_type="text">ASCCP recommends initial colposcopy [6,26]. If the col-</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="74" segment_no="10" tag_type="text">poscopic evaluation in the LSIL-H management algorithm</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="75" segment_no="10" tag_type="text">suggested in Figure 4 is negative, the cytology and biopsy<a href="">e 5). </a>For ASC-H and LSIL,</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="76" segment_no="10" tag_type="text">material should be reviewed. If the review leads to a<a href="">[6,26</a>]. If the col-</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="77" segment_no="10" tag_type="text">change in the interpretation, one should follow the</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="78" segment_no="10" tag_type="text">appropriate ASCCP algorithm [6,26]. As compared to the<a href="">4</a> is negative, the cytology and biopsy</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="79" segment_no="10" tag_type="text">choice of following either the LSIL or ASC-H algorithm,</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="80" segment_no="10" tag_type="text">the application of the suggested guidelines will require a</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="81" segment_no="7" tag_type="text">relatively small proportion (approximately 1 out of four<a href="">6,26]</a>. As compared to the</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="82" segment_no="7" tag_type="text">cases) of already rare LSIL-H cases to go through slightly</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="83" segment_no="7" tag_type="text">increased number of clinical encounters (Figure 5). These</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="84" segment_no="7" tag_type="text">guidelines may be evaluated comparatively with other</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="85" segment_no="7" tag_type="text">possible alternative combinations to refine it further as</text>
<text top="380" left="313" width="184" height="9" font="font4" id="p1_t43" reading_order_no="86" segment_no="7" tag_type="text">indicated by follow up studies in the future.<a href="">5). Thes</a>e</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="87" segment_no="9" tag_type="text">Another alternative to LSIL-H as a distinct category is to</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="88" segment_no="9" tag_type="text">continue with current approach of communicating two</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="89" segment_no="9" tag_type="text">distinct interpretations, LSIL and ASC-H, for a given single</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="90" segment_no="9" tag_type="text">cervical specimen. Although this approach accommodates</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="91" segment_no="9" tag_type="text">2001 Bethesda System terminology, it has several disad-</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="92" segment_no="9" tag_type="text">vantages, including difficulties in organizing quality</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="93" segment_no="9" tag_type="text">assurance statistics. This, however, may interfere with the</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="94" segment_no="9" tag_type="text">management approach based on current ASCCP guide-</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="95" segment_no="9" tag_type="text">lines [6,22-25]. The current recommendation is to refer</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="96" segment_no="9" tag_type="text">both LSIL and ASC-H cases to colposcopy, but LSIL-H</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="97" segment_no="9" tag_type="text">cases have a significantly lower chance of negative results</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="98" segment_no="9" tag_type="text">(Table 1), and so relatively aggressive follow up steps may<a href="">[6,22-25]. Th</a>e current recommendation is to refer</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="99" segment_no="9" tag_type="text">be indicated at later stages of management. Another chal-</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="100" segment_no="9" tag_type="text">lenge is difficulty in verifying the risk of progression to</text>
<text top="568" left="313" width="222" height="9" font="font4" id="p1_t58" reading_order_no="101" segment_no="9" tag_type="text">high grade dysplasia for two separate interpretations.<a href="">(Table 1)</a>, and so relatively aggressive follow up steps may</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="102" segment_no="11" tag_type="text">HPV DNA testing has been suggested to be a simple alter-</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="103" segment_no="11" tag_type="text">native with sensitivity and negative predictive value</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="104" segment_no="11" tag_type="text">approaching 100% for detecting HSIL [26-29]. The role of</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="105" segment_no="11" tag_type="text">HPV testing in primary screening of cervical cancer cur-</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="106" segment_no="11" tag_type="text">rently has been effective in the ASCUS category. Its role in</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="107" segment_no="11" tag_type="text">other categories is evolving. It has also been reported to be<a href=""> [26-29]. Th</a>e role of</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="108" segment_no="11" tag_type="text">helpful in ASC-H cases [27]. However, in LSIL-H, most of</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="109" segment_no="11" tag_type="text">the cases are expected to be positive for HPV testing and</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="110" segment_no="11" tag_type="text">so its role may be limited. In the current study, coinciden-</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="111" segment_no="11" tag_type="text">tal observation of HPV test results were available in 34 out<a href="">s [27]</a>. However, in LSIL-H, most of</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="112" segment_no="11" tag_type="text">of total 88 LSIL-H cases. HPV testing was positive for high</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="113" segment_no="11" tag_type="text">risk HPV in 94% (32 out of 34). Cervical biopsy in two</text>
<text top="87" left="55" width="218" height="7" font="font5" id="p1_t71" reading_order_no="2" segment_no="2" tag_type="title">Table 1: Biopsy results for LSIL, LSIL-H, ASC-H, and HSIL</text>
<text top="105" left="59" width="61" height="7" font="font5" id="p1_t72" reading_order_no="3" segment_no="3" tag_type="table">Cytopathologic</text>
<text top="114" left="59" width="57" height="7" font="font5" id="p1_t73" reading_order_no="4" segment_no="3" tag_type="table">interpretation</text>
<text top="123" left="59" width="53" height="7" font="font5" id="p1_t74" reading_order_no="5" segment_no="3" tag_type="table">in SurePath ™<b>Table 1: Biopsy results for LSIL, LSIL-H, ASC-H, and HSIL</b></text>
<text top="105" left="273" width="132" height="7" font="font5" id="p1_t75" reading_order_no="6" segment_no="3" tag_type="table">Positive predictive value (PPV) for<b>Cytopathologic </b></text>
<text top="146" left="171" width="34" height="7" font="font5" id="p1_t76" reading_order_no="7" segment_no="3" tag_type="table">Group A<b>interpretation </b></text>
<text top="155" left="139" width="100" height="7" font="font5" id="p1_t77" reading_order_no="8" segment_no="3" tag_type="table">Negative result on biopsy<b>in SurePath</b></text>
<text top="146" left="297" width="33" height="7" font="font5" id="p1_t78" reading_order_no="9" segment_no="3" tag_type="table">Group B</text>
<text top="155" left="263" width="104" height="7" font="font5" id="p1_t79" reading_order_no="10" segment_no="3" tag_type="table">Low grade (HPV &amp; CIN-1)<b>Positive predictive value (PPV) for</b></text>
<text top="164" left="283" width="61" height="7" font="font5" id="p1_t80" reading_order_no="11" segment_no="3" tag_type="table">result on biopsy<b>Group A</b></text>
<text top="146" left="423" width="34" height="7" font="font5" id="p1_t81" reading_order_no="12" segment_no="3" tag_type="table">Group C<b>Negative result on biopsy </b></text>
<text top="155" left="385" width="111" height="7" font="font5" id="p1_t82" reading_order_no="13" segment_no="3" tag_type="table">High grade (CIN-2 &amp; CIN-3)<b>Group B</b></text>
<text top="164" left="409" width="63" height="7" font="font5" id="p1_t83" reading_order_no="14" segment_no="3" tag_type="table">result on biopsy<b>Low grade (HPV &amp; CIN-1) </b></text>
<text top="146" left="507" width="43" height="7" font="font5" id="p1_t84" reading_order_no="15" segment_no="3" tag_type="table">Total (792)<b>result on biopsy</b></text>
<text top="186" left="59" width="5" height="7" font="font5" id="p1_t85" reading_order_no="16" segment_no="3" tag_type="table">1<b>Group C</b></text>
<text top="186" left="76" width="22" height="7" font="font5" id="p1_t86" reading_order_no="17" segment_no="3" tag_type="table">LSIL*<b>High grade (CIN-2 &amp; CIN-3) </b></text>
<text top="186" left="163" width="48" height="7" font="font6" id="p1_t87" reading_order_no="18" segment_no="3" tag_type="table">32% (179/557)<b>result on biopsy </b></text>
<text top="186" left="289" width="48" height="7" font="font6" id="p1_t88" reading_order_no="19" segment_no="3" tag_type="table">58% (323/557)<b>Total (792)</b></text>
<text top="186" left="414" width="51" height="7" font="font5" id="p1_t89" reading_order_no="20" segment_no="3" tag_type="table">10% b (55/557)<b>1</b></text>
<text top="186" left="510" width="38" height="7" font="font6" id="p1_t90" reading_order_no="21" segment_no="3" tag_type="table">100% (557)<b>LSIL*</b></text>
<text top="197" left="59" width="5" height="7" font="font5" id="p1_t91" reading_order_no="22" segment_no="3" tag_type="table">2</text>
<text top="197" left="76" width="31" height="7" font="font5" id="p1_t92" reading_order_no="23" segment_no="3" tag_type="table">LSIL-H*</text>
<text top="196" left="165" width="46" height="8" font="font5" id="p1_t93" reading_order_no="24" segment_no="3" tag_type="table">24% a (21/88)<b>10% </b></text>
<text top="196" left="292" width="43" height="8" font="font8" id="p1_t94" reading_order_no="25" segment_no="3" tag_type="table">43% c (38/88)</text>
<text top="196" left="418" width="43" height="8" font="font6" id="p1_t95" reading_order_no="26" segment_no="3" tag_type="table">33% b (29/88)<b>(55/557)</b></text>
<text top="197" left="512" width="34" height="7" font="font6" id="p1_t96" reading_order_no="27" segment_no="3" tag_type="table">100% (88)</text>
<text top="207" left="59" width="5" height="7" font="font5" id="p1_t97" reading_order_no="28" segment_no="3" tag_type="table">3<b>2</b></text>
<text top="207" left="76" width="31" height="7" font="font5" id="p1_t98" reading_order_no="29" segment_no="3" tag_type="table">ASC-H*<b>LSIL-H*</b></text>
<text top="207" left="167" width="42" height="7" font="font6" id="p1_t99" reading_order_no="30" segment_no="3" tag_type="table">32% a (12/38)<b>24%</b></text>
<text top="207" left="291" width="45" height="7" font="font8" id="p1_t100" reading_order_no="31" segment_no="3" tag_type="table">37% c (14/38)</text>
<text top="207" left="418" width="43" height="7" font="font6" id="p1_t101" reading_order_no="32" segment_no="3" tag_type="table">31% b (12/38)<b>(21/88)</b></text>
<text top="207" left="512" width="34" height="7" font="font6" id="p1_t102" reading_order_no="33" segment_no="3" tag_type="table">100% (38)<i>43%</i></text>
<text top="217" left="59" width="5" height="7" font="font5" id="p1_t103" reading_order_no="34" segment_no="3" tag_type="table">4</text>
<text top="217" left="76" width="20" height="7" font="font5" id="p1_t104" reading_order_no="35" segment_no="3" tag_type="table">HSIL</text>
<text top="217" left="170" width="36" height="7" font="font6" id="p1_t105" reading_order_no="36" segment_no="3" tag_type="table">5% (6/109)</text>
<text top="217" left="292" width="44" height="7" font="font6" id="p1_t106" reading_order_no="37" segment_no="3" tag_type="table">26% (28/109)</text>
<text top="217" left="417" width="44" height="7" font="font6" id="p1_t107" reading_order_no="38" segment_no="3" tag_type="table">69% (75/109)</text>
<text top="217" left="510" width="38" height="7" font="font6" id="p1_t108" reading_order_no="39" segment_no="3" tag_type="table">100% (109)</text>
<text top="239" left="59" width="492" height="7" font="font6" id="p1_t109" reading_order_no="40" segment_no="4" tag_type="text">* Positive predictive values between groups 1,2,&amp;3 were compared by performing separate 2 × 3 Chi-square tests for rows 1 &amp; 2 and for rows 2 &amp;<b>3</b></text>
<text top="249" left="59" width="491" height="7" font="font6" id="p1_t110" reading_order_no="41" segment_no="4" tag_type="text">3. Applying the Bonferroni correction for multiple testing the significance level was adjusted to 0.025. The statistical comparison between LSIL and<b>ASC-H*</b></text>
<text top="258" left="59" width="481" height="7" font="font6" id="p1_t111" reading_order_no="42" segment_no="4" tag_type="text">LSIL-H shows Chi-square value of 35.7 with p value less than 0.001, consistent with statistically significant difference between these two groups</text>
<text top="267" left="59" width="487" height="7" font="font6" id="p1_t112" reading_order_no="43" segment_no="4" tag_type="text">indicating they represent two separate entities. However, for LSIL-H and ASC-H the Chi-square is 0.87 with p value nearly equal to 1, consistent</text>
<text top="276" left="59" width="216" height="7" font="font6" id="p1_t113" reading_order_no="44" segment_no="4" tag_type="text">with lack of any significant difference between these two groups.</text>
<text top="285" left="59" width="491" height="8" font="font6" id="p1_t114" reading_order_no="45" segment_no="5" tag_type="text">LSIL-H b and ASC-H b showed higher PPV for high grade dysplasia on biopsy, but prevalence of negative results was lower for LSIL-H, as compared to<i>37% </i></text>
<text top="295" left="59" width="478" height="7" font="font6" id="p1_t115" reading_order_no="46" segment_no="5" tag_type="text">ASC-H a . In summary, LSIL-H overlapped on one side with ASC-H for high grade risk, and with LSIL on other side for higher risk for low grade</text>
<text top="304" left="59" width="355" height="7" font="font6" id="p1_t116" reading_order_no="47" segment_no="5" tag_type="text">lesion c . The possibility of negative result with LSIL-H a was intermediate between HSIL and LSIL or ASC-H.</text>
</page>
</pdf2xml>
